Chronos Archive seal
The Human Record

Joe Frazier

Case HR-BX004-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
January 12, 1944 – November 7, 2011
Synthetic DOB
1944-01-12
Index visit
2008-02-16 at age 64
Synthetic MRN
HR-BX004-SYN-TD

Teaching objective: Type 2 diabetes and hypertension in a 64-year-old Black man, a former professional heavyweight boxer who runs a gym, managed under the ADA Standards of Care 2008, the 2007 AHA/ACC blood pressure guideline and the CMID monographs: A1c, kidney function by the race-free CKD-EPI 2003 equation and urine albumin, lipids and a high-intensity statin, a GLP-1 receptor agonist with cardiovascular and kidney benefit, blood pressure to below 130/80 with home readings, eye and foot examinations, and cost and access. The yearly liver check finds a high FIB-4, and the AASLD 2005 MASLD guidance leads to elastography and a diagnosis of compensated cirrhosis from MASLD; under the AASLD 2005 hepatocellular carcinoma guidance he begins ultrasound with AFP every six months, the kind of surveillance that can find liver cancer early, with variceal screening, vaccines and no alcohol. Brain health in a former boxer is addressed with a documented cognitive screen and risk-factor care, and without a diagnosis of chronic traumatic encephalopathy, which can be made only after death.

Historical timeline

DateEventClaims
January 12, 1944Born in Beaufort County, South Carolina.CLM-0001
late 1950sMoved to Philadelphia as a teenager; worked in a slaughterhouse.CLM-0002
1964Olympic heavyweight gold medal in Tokyo, with a broken left thumb; a cataract found in his left eye later that year.CLM-0003, CLM-0004
February 16, 1970Became undisputed heavyweight champion.CLM-0005
1975Third fight of his rivalry, stopped before the fifteenth round when he could not see; vision 20/400 in the left eye.CLM-0004, CLM-0006
1976Retired from boxing (one further bout in 1981).CLM-0005
1996Published his autobiography, Smokin' Joe.CLM-0011
early 2000sLiving in Philadelphia and running his gym; diabetes and high blood pressure reported publicly.CLM-0007, CLM-0008
October 2011Diagnosed with liver cancer; hospice care at home in his last week.CLM-0009
November 7, 2011Died in Philadelphia at 67.CLM-0010

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Joe Frazier was born on January 12, 1944, in Beaufort County, South Carolina, the eleventh child of a sharecropping family. confirmed Sielski M. Joe Frazier biography (ESPN Classic) supports
Boxing legend Joe Frazier dies supports
Gelston D, Dahlberg T. Philadelphia boxing legend Joe Frazier dies (Associated Press) supports
Cancer catches Joe Frazier supports
HISTMED Master Roster v3 context
D As a teenager he moved to Philadelphia, where he had relatives, and worked in a slaughterhouse, where he punched sides of beef in the cold room.
Anchors his Philadelphia home and working life in the modern social history.
confirmed Sielski M. Joe Frazier biography (ESPN Classic) supports
D He won the heavyweight gold medal at the 1964 Olympic Games in Tokyo, fighting the final with a broken left thumb. confirmed Sielski M. Joe Frazier biography (ESPN Classic) supports
Gelston D, Dahlberg T. Philadelphia boxing legend Joe Frazier dies (Associated Press) supports
Boxing legend Joe Frazier dies supports
Cancer catches Joe Frazier supports
D Later in 1964 he learned that he had a cataract in his left eye; visually impaired, he turned professional anyway. The cataract grew worse, and by 1975, according to his eye doctor, his vision was 20/50 in the right eye and 20/400 in the left.
Reported during his life. Anchors the reduced vision in the left eye in the modern episode. Later accounts that he hid the eye from examiners appeared only after his death and are not used.
confirmed Sielski M. Joe Frazier biography (ESPN Classic) supports
Diskin B. Smokin' Joe had vicious left hook (ESPN Classic) supports
D He became undisputed world heavyweight champion in February 1970 and held the title until January 1973, defending it four times; he retired in 1976 after a professional record of 32 wins, 4 losses and 1 draw, with 27 knockouts, and returned for a single bout in 1981.
Anchors a long professional career with many blows to the head, the basis for brain-health care in the modern episode.
confirmed Sielski M. Joe Frazier biography (ESPN Classic) supports
Joe Frazier dead at 67 (Associated Press) supports
Gelston D, Dahlberg T. Philadelphia boxing legend Joe Frazier dies (Associated Press) supports
D His three-fight rivalry in the 1970s included a 1971 victory that handed his opponent his first professional defeat; in the third fight, in Manila in 1975, he could no longer see, and his trainer would not let him come out for the fifteenth round.
History only; the opponent is not named in this record.
confirmed Gelston D, Dahlberg T. Philadelphia boxing legend Joe Frazier dies (Associated Press) supports
Sielski M. Joe Frazier biography (ESPN Classic) supports
Joe Frazier dead at 67 (Associated Press) supports
D In later life he lived in Philadelphia, where he owned and ran a boxing gym, and he had financial trouble.
Anchors his work at the gym and cost concerns in the modern social history.
confirmed Sielski M. Joe Frazier biography (ESPN Classic) supports
Gelston D, Dahlberg T. Philadelphia boxing legend Joe Frazier dies (Associated Press) supports
D During his life it was reported publicly that he had diabetes and high blood pressure.
The anchor for the modern diabetes and hypertension; the duration, severity and treatment in the modern episode are synthetic.
confirmed Sielski M. Joe Frazier biography (ESPN Classic) supports
D In October 2011 he was diagnosed with liver cancer; he was in and out of the hospital from early October and received hospice care at home in his last week.
History after the modern episode, as his manager and a family friend stated publicly. The modern episode contains no liver cancer; its teaching point is surveillance that can find liver cancer early.
confirmed Joe Frazier dead at 67 (Associated Press) supports
Ex-champ Frazier dies of liver cancer (Associated Press) supports
Cancer catches Joe Frazier supports
D He died on November 7, 2011, in Philadelphia, at 67, after a brief illness with liver cancer.
History only, recorded in one plain sentence.
confirmed Joe Frazier dead at 67 (Associated Press) supports
Boxing legend Joe Frazier dies supports
Gelston D, Dahlberg T. Philadelphia boxing legend Joe Frazier dies (Associated Press) supports
D He published an autobiography, Smokin' Joe, in 1996.
His nickname, used here as an alias.
confirmed Sielski M. Joe Frazier biography (ESPN Classic) supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Type 2 diabetes with hyperglycemia, about twelve years' duration, A1c 8.4% on metformin; synthetic modern episode linked to his publicly reported diabetes active confirmed both_with_link CLM-0008
S Hypertension above goal on lisinopril (152/92 mmHg in the clinic); synthetic modern episode linked to his publicly reported high blood pressure active confirmed both_with_link CLM-0008
S Raised AST (48 U/L) with mildly low platelets (138) and a FIB-4 score of 3.43 at the yearly liver check, to be evaluated resolved confirmed active
S Metabolic dysfunction-associated steatotic liver disease (MASLD): steatosis on elastography (controlled attenuation parameter 318 dB/m) and ultrasound, with diabetes, obesity, low HDL and high triglycerides, and little alcohol active confirmed active
S Compensated cirrhosis (compensated advanced chronic liver disease) from MASLD: liver stiffness 17.6 kPa, platelets 138, nodular liver surface and a spleen of 13.4 cm on ultrasound; no ascites, encephalopathy, bleeding or jaundice; Child-Pugh A active confirmed active
S Hyperlipidemia: LDL 132 mg/dL, HDL 38 and triglycerides 210, not on a statin active confirmed active
S Obesity, class 1 (BMI 31.4) active confirmed active
S Reduced vision in the left eye since a cataract found at 20 (counting fingers at 1 meter); right eye 20/30 active confirmed active CLM-0004

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2008-02-16 Hemoglobin A1c/Hemoglobin.total in Blood 8.4% (high)
Reference Below 5.7% is normal; goal below 7% for him
http://loinc.org · 4548-4
S 2008-02-16 Glucose [Mass/volume] in Serum or Plasma 168 mg/dL (high)
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2008-02-16 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2008-02-16 Potassium [Moles/volume] in Serum or Plasma 4.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2008-02-16 Creatinine [Mass/volume] in Serum or Plasma 1.08 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2008-02-16 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2003)/1.73 sq M 77 mL/min/1.73 m²
Reference 60 or higher without kidney damage markers is not CKD
http://loinc.org · 98979-8
S 2008-02-16 Albumin/Creatinine [Mass Ratio] in Urine 18 mg/g
Reference Below 30 mg/g is normal (A1)
http://loinc.org · 9318-7
S 2008-02-16 Cholesterol [Mass/volume] in Serum or Plasma 212 mg/dL (high)
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2008-02-16 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 132 mg/dL (high)
Reference Goal below 70 mg/dL with diabetes and other risk factors
http://loinc.org · 13457-7
S 2008-02-16 Cholesterol in HDL [Mass/volume] in Serum or Plasma 38 mg/dL (low)
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 2008-02-16 Triglyceride [Mass/volume] in Serum or Plasma 210 mg/dL (high)
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2008-02-16 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 48 U/L (high)
Reference 10-40 U/L
http://loinc.org · 1920-8
S 2008-02-16 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 42 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 2008-02-16 Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 96 U/L
Reference 40-129 U/L
http://loinc.org · 6768-6
S 2008-02-16 Albumin [Mass/volume] in Serum or Plasma 4 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 2008-02-16 Bilirubin.total [Mass/volume] in Serum or Plasma 0.9 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 2008-02-16 Hemoglobin [Mass/volume] in Blood 14.2 g/dL
Reference 13.5-17.5 g/dL
http://loinc.org · 718-7
S 2008-02-16 Platelets [#/volume] in Blood by Automated count 138 10*3/uL (low)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2008-02-16 Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 340 pg/mL
Reference 232-1245 pg/mL
http://loinc.org · 2132-9
S 2008-02-16 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 2008-02-16 Total score [AUDIT-C] 2 http://loinc.org · 75626-2
S 2008-03-02 Liver stiffness by US.transient elastography 17.6 kPa (high)
Reference Below 8 kPa makes advanced fibrosis unlikely; 15 kPa or higher is consistent with compensated advanced chronic liver disease
http://loinc.org · 77615-3
S 2008-03-02 INR in Platelet poor plasma by Coagulation assay 1.1
Reference 0.8-1.2
http://loinc.org · 6301-6
S 2008-03-02 Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma 4.2 ng/mL
Reference <=8.3 ng/mL
http://loinc.org · 1834-1
S 2008-04-13 Potassium [Moles/volume] in Serum or Plasma 4.7 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2008-04-13 Creatinine [Mass/volume] in Serum or Plasma 1.1 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2008-04-13 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2003)/1.73 sq M 75 mL/min/1.73 m²
Reference 60 or higher without kidney damage markers is not CKD
http://loinc.org · 98979-8
S 2008-04-13 Cholesterol [Mass/volume] in Serum or Plasma 148 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2008-04-13 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 68 mg/dL
Reference Goal below 70 mg/dL with diabetes and other risk factors
http://loinc.org · 13457-7
S 2008-04-13 Cholesterol in HDL [Mass/volume] in Serum or Plasma 40 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 2008-04-13 Triglyceride [Mass/volume] in Serum or Plasma 168 mg/dL (high)
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2008-04-13 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 44 U/L (high)
Reference 10-40 U/L
http://loinc.org · 1920-8
S 2008-04-13 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 40 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 2008-05-18 Hemoglobin A1c/Hemoglobin.total in Blood 7.3% (high)
Reference Below 5.7% is normal; goal below 7% for him
http://loinc.org · 4548-4
S 2008-07-13 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 2008-07-13 Total score [MoCA] 26 http://loinc.org · 72172-0
S 2008-09-14 Hemoglobin A1c/Hemoglobin.total in Blood 6.8% (high)
Reference Below 5.7% is normal; goal below 7% for him
http://loinc.org · 4548-4
S 2008-09-14 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2008-09-14 Potassium [Moles/volume] in Serum or Plasma 4.5 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2008-09-14 Creatinine [Mass/volume] in Serum or Plasma 1.06 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2008-09-14 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2003)/1.73 sq M 78 mL/min/1.73 m²
Reference 60 or higher without kidney damage markers is not CKD
http://loinc.org · 98979-8
S 2008-09-14 Albumin/Creatinine [Mass Ratio] in Urine 14 mg/g
Reference Below 30 mg/g is normal (A1)
http://loinc.org · 9318-7
S 2008-09-14 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 38 U/L
Reference 10-40 U/L
http://loinc.org · 1920-8
S 2008-09-14 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 2008-09-14 Albumin [Mass/volume] in Serum or Plasma 4.1 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 2008-09-14 Bilirubin.total [Mass/volume] in Serum or Plasma 0.8 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 2008-09-14 Platelets [#/volume] in Blood by Automated count 140 10*3/uL (low)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2008-09-14 Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma 4 ng/mL
Reference <=8.3 ng/mL
http://loinc.org · 1834-1

Synthetic vital signs

DateMeasureResultLOINCGrade
2008-02-16Body height182 cm8302-2S
2008-02-16Body weight104 kg29463-7S
2008-02-16Body mass index (BMI) [Ratio]31.4 kg/m239156-5S
2008-02-16Systolic blood pressure152 mm[Hg]8480-6S
2008-02-16Diastolic blood pressure92 mm[Hg]8462-4S
2008-02-16Heart rate76 /min8867-4S
2008-02-16Respiratory rate16 /min9279-1S
2008-02-16Body temperature36.7 Cel8310-5S
2008-02-16Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
2008-03-02Body height182 cm8302-2S
2008-03-02Body weight103.6 kg29463-7S
2008-03-02Body mass index (BMI) [Ratio]31.3 kg/m239156-5S
2008-03-02Systolic blood pressure148 mm[Hg]8480-6S
2008-03-02Diastolic blood pressure90 mm[Hg]8462-4S
2008-03-02Heart rate74 /min8867-4S
2008-03-02Respiratory rate16 /min9279-1S
2008-03-02Body temperature36.6 Cel8310-5S
2008-03-02Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
2008-04-13Body height182 cm8302-2S
2008-04-13Body weight101.8 kg29463-7S
2008-04-13Body mass index (BMI) [Ratio]30.7 kg/m239156-5S
2008-04-13Systolic blood pressure134 mm[Hg]8480-6S
2008-04-13Diastolic blood pressure82 mm[Hg]8462-4S
2008-04-13Heart rate72 /min8867-4S
2008-04-13Respiratory rate16 /min9279-1S
2008-04-13Body temperature36.7 Cel8310-5S
2008-04-13Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2008-05-18Body height182 cm8302-2S
2008-05-18Body weight99.9 kg29463-7S
2008-05-18Body mass index (BMI) [Ratio]30.2 kg/m239156-5S
2008-05-18Systolic blood pressure126 mm[Hg]8480-6S
2008-05-18Diastolic blood pressure78 mm[Hg]8462-4S
2008-05-18Heart rate74 /min8867-4S
2008-05-18Respiratory rate16 /min9279-1S
2008-05-18Body temperature36.6 Cel8310-5S
2008-05-18Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2008-09-14Body height182 cm8302-2S
2008-09-14Body weight97.2 kg29463-7S
2008-09-14Body mass index (BMI) [Ratio]29.3 kg/m239156-5S
2008-09-14Systolic blood pressure122 mm[Hg]8480-6S
2008-09-14Diastolic blood pressure76 mm[Hg]8462-4S
2008-09-14Heart rate72 /min8867-4S
2008-09-14Respiratory rate16 /min9279-1S
2008-09-14Body temperature36.7 Cel8310-5S
2008-09-14Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2008-07-13Body height182 cm8302-2S
2008-07-13Body weight98.6 kg29463-7S
2008-07-13Body mass index (BMI) [Ratio]29.8 kg/m239156-5S
2008-07-13Systolic blood pressure124 mm[Hg]8480-6S
2008-07-13Diastolic blood pressure76 mm[Hg]8462-4S
2008-07-13Heart rate72 /min8867-4S
2008-07-13Respiratory rate16 /min9279-1S
2008-07-13Body temperature36.6 Cel8310-5S
2008-07-13Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
A1c below 7% within six to nine months, without low blood sugar2008-09-14completed8.4% to 6.8% at seven months; no low blood sugar
Blood pressure below 130/80 mmHg in the clinic and at home2008-09-14completed122/76 in the clinic; home average 124/78
LDL cholesterol below 70 mg/dL2008-04-13completed132 to 68 mg/dL on atorvastatin
Weight loss of 7 to 10% for liver health within a year2008-09-14active104.0 to 97.2 kg (6.5%) at seven months
Liver cancer surveillance by ultrasound with AFP every six months, on time2008-09-14completedBaseline and six-month ultrasounds with AFP on schedule; no focal lesion; AFP 4.2 and 4.0 ng/mL
No alcohol, to protect the liver2008-09-14completedNo alcohol since the two-week visit

Interventions

InterventionStatusGuideline
Diabetes: continue metformin, an A1c every three months until at goal and then every six months, diabetes self-management education, a vitamin B12 check on long-term metformin, and no medicine that causes low blood sugarcompletedGL-ADA-PHARM-2026, GL-CMID-2026
Hepatology consultation for a high FIB-4 with mildly low platelets, with transient elastography and a liver ultrasound the same daycompletedGL-AASLD-MASLD-2023, GL-ADA-COMORB-2026
Liver assessment: FIB-4 from the yearly liver tests, then transient elastography if FIB-4 is 1.3 or higher; hepatitis B, hepatitis C and HIV tests, iron studies, and an alcohol historycompletedGL-AASLD-MASLD-2023, GL-ADA-COMORB-2026, GL-CMID-2026
Compensated cirrhosis: liver ultrasound with AFP every six months for hepatocellular carcinoma surveillance, upper endoscopy to screen for varices, hepatitis A and B and pneumococcal vaccines, no alcohol, no NSAIDs, acetaminophen no more than 2 g a day, and teaching on the warning signs of decompensationcompletedGL-AASLD-HCC-2023, GL-BAVENO-VII, GL-AASLD-MASLD-2023, GL-CDC-IMZ-2026
Semaglutide once weekly, increased every four to eight weeks as tolerated, for its cardiovascular and kidney benefit, weight and steatotic liver disease; prior authorization and the manufacturer's assistance program handled by the cliniccompletedGL-ADA-PHARM-2026, GL-ADA-COMORB-2026, GL-AASLD-MASLD-2023
Blood pressure: a validated home monitor with a large cuff, readings twice a day for a week, a goal below 130/80 mmHg, and less saltcompletedGL-AHA-HTN-2025, GL-CMID-2026
Amlodipine added to lisinopril and increased to reach the goal, with ankle-swelling checkscompletedGL-AHA-HTN-2025, GL-ADA-CVD-2026
Cardiovascular risk: atorvastatin 40 mg with a lipid panel at four to twelve weeks; a baseline ECG; aspirin for primary prevention not used because of bleeding riskcompletedGL-ADA-CVD-2026, GL-CMID-2026
Kidneys: eGFR by the race-free CKD-EPI 2003 equation and urine albumin-to-creatinine ratio at least yearly, and potassium and creatinine on lisinoprilcompletedGL-ADA-CKD-2026, GL-CMID-2026
Eyes and feet: a dilated eye examination at the eye clinic, a comprehensive foot examination yearly, daily foot checks and callus carecompletedGL-ADA-RETFOOT-2026
Brain health: a documented cognitive screen at the preventive visit, blood pressure and glucose control, sleep, hearing and mood checks, and an honest conversation that chronic traumatic encephalopathy cannot be diagnosed during lifecompletedGL-NINDS-TES-2021, GL-CMID-2026
Cost and access: low-cost generics, 90-day supplies, and help with coverage for any brand-name medicinecompletedGL-ADA-POP-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Sielski M. Joe Frazier biography (ESPN Classic) ESPN biography
SRC-0002 Diskin B. Smokin' Joe had vicious left hook (ESPN Classic) ESPN other
SRC-0003 Boxing legend Joe Frazier dies ESPN.com news services other
SRC-0004 Gelston D, Dahlberg T. Philadelphia boxing legend Joe Frazier dies (Associated Press) The Philadelphia Inquirer other
SRC-0005 Joe Frazier dead at 67 (Associated Press) CBS Los Angeles other
SRC-0006 Ex-champ Frazier dies of liver cancer (Associated Press) The Vindicator other
SRC-0007 Cancer catches Joe Frazier The Irish Times other
SRC-0008 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the FIB-4 to elastography pathway, the diagnosis of compensated cirrhosis from a liver stiffness of 17.6 kPa with platelets of 138 and ultrasound findings, the endoscopy rather than a beta-blocker, six-monthly ultrasound with AFP, semaglutide with metformin, the eGFR without a race term, amlodipine with lisinopril, aspirin not used, and the cognitive screen without a CTE diagnosis.
provenance reviewnot_startedSources: an ESPN Classic biography and an ESPN Classic article written during his life, and obituaries from ESPN, the Associated Press (The Philadelphia Inquirer, CBS Los Angeles, The Vindicator) and The Irish Times. A posthumous magazine profile was not used.
safe messaging reviewnot_startedRecent-death rule: only what was reported publicly during his life or in obituaries and statements by his manager and family. No sick visit. No mental health or substance claim is made. The liver disease, cognitive screen and every clinical finding are synthetic. No living relative is named, and his rival is not named.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.